Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 39 entries
Sorted by: Best Match Show Resources per page
Prevalence of spinocerebellar ataxia 36 in a US population.

Neurology. Genetics

Valera JM, Diaz T, Petty LE, Quintáns B, Yáñez Z, Boerwinkle E, Muzny D, Akhmedov D, Berdeaux R, Sobrido MJ, Gibbs R, Lupski JR, Geschwind DH, Perlman S, Below JE, Fogel BL.
PMID: 28761930
Neurol Genet. 2017 Jul 18;3(4):e174. doi: 10.1212/NXG.0000000000000174. eCollection 2017 Aug.

OBJECTIVE: To assess the prevalence and clinical features of individuals affected by spinocerebellar ataxia 36 (SCA36) at a large tertiary referral center in the United States.METHODS: A total of 577 patients with undiagnosed sporadic or familial cerebellar ataxia comprehensively...

Cite
Valera JM, Diaz T, Petty LE, et al. Prevalence of spinocerebellar ataxia 36 in a US population. Neurol Genet. 2017;3(4):e174doi: 10.1212/NXG.0000000000000174.
Valera, J. M., Diaz, T., Petty, L. E., Quintáns, B., Yáñez, Z., Boerwinkle, E., Muzny, D., Akhmedov, D., Berdeaux, R., Sobrido, M. J., Gibbs, R., Lupski, J. R., Geschwind, D. H., Perlman, S., Below, J. E., & Fogel, B. L. (2017). Prevalence of spinocerebellar ataxia 36 in a US population. Neurology. Genetics, 3(4), e174. https://doi.org/10.1212/NXG.0000000000000174
Valera, Juliana M, et al. "Prevalence of spinocerebellar ataxia 36 in a US population." Neurology. Genetics vol. 3,4 (2017): e174. doi: https://doi.org/10.1212/NXG.0000000000000174
Valera JM, Diaz T, Petty LE, Quintáns B, Yáñez Z, Boerwinkle E, Muzny D, Akhmedov D, Berdeaux R, Sobrido MJ, Gibbs R, Lupski JR, Geschwind DH, Perlman S, Below JE, Fogel BL. Prevalence of spinocerebellar ataxia 36 in a US population. Neurol Genet. 2017 Jul 18;3(4):e174. doi: 10.1212/NXG.0000000000000174. eCollection 2017 Aug. PMID: 28761930; PMCID: PMC5515602.
Copy Download .nbib Format: NLM
Stimulation of the Epithelial Na.

Frontiers in physiology

Soares AG, Contreras J, Archer CR, Mironova E, Berdeaux R, Stockand JD, Abd El-Aziz TM.
PMID: 34512393
Front Physiol. 2021 Aug 25;12:725782. doi: 10.3389/fphys.2021.725782. eCollection 2021.

The activity of the Epithelial Na

Cite
Soares AG, Contreras J, Archer CR, et al. Stimulation of the Epithelial Na. Front Physiol. 2021;12:725782doi: 10.3389/fphys.2021.725782.
Soares, A. G., Contreras, J., Archer, C. R., Mironova, E., Berdeaux, R., Stockand, J. D., & Abd El-Aziz, T. M. (2021). Stimulation of the Epithelial Na. Frontiers in physiology, 12725782. https://doi.org/10.3389/fphys.2021.725782
Soares, Antonio G, et al. "Stimulation of the Epithelial Na." Frontiers in physiology vol. 12 (2021): 725782. doi: https://doi.org/10.3389/fphys.2021.725782
Soares AG, Contreras J, Archer CR, Mironova E, Berdeaux R, Stockand JD, Abd El-Aziz TM. Stimulation of the Epithelial Na. Front Physiol. 2021 Aug 25;12:725782. doi: 10.3389/fphys.2021.725782. eCollection 2021. PMID: 34512393; PMCID: PMC8425396.
Copy Download .nbib Format: NLM
Spectacle independence and subjective satisfaction of ReSTOR multifocal intraocular lens after cataract or presbyopia surgery in two European countries.

Clinical ophthalmology (Auckland, N.Z.)

Cochener B, Fernández-Vega L, Alfonso JF, Maurel F, Meunier J, Berdeaux G.
PMID: 20234773
Clin Ophthalmol. 2010 Mar 04;4:81-9. doi: 10.2147/opth.s9403.

PURPOSE: To determine the percentage of patients implanted bilaterally with ReSTOR((R)) requiring spectacles at 18 months, the patient satisfaction, and factors that predict spectacles independence.METHODS: The medical and surgical data were collected from patient records. The 'Freedom from Spectacles...

Cite
Cochener B, Fernández-Vega L, Alfonso JF, et al. Spectacle independence and subjective satisfaction of ReSTOR multifocal intraocular lens after cataract or presbyopia surgery in two European countries. Clin Ophthalmol. 2010;4:81-9doi: 10.2147/opth.s9403.
Cochener, B., Fernández-Vega, L., Alfonso, J. F., Maurel, F., Meunier, J., & Berdeaux, G. (2010). Spectacle independence and subjective satisfaction of ReSTOR multifocal intraocular lens after cataract or presbyopia surgery in two European countries. Clinical ophthalmology (Auckland, N.Z.), 481-9. https://doi.org/10.2147/opth.s9403
Cochener, Béatrice, et al. "Spectacle independence and subjective satisfaction of ReSTOR multifocal intraocular lens after cataract or presbyopia surgery in two European countries." Clinical ophthalmology (Auckland, N.Z.) vol. 4 (2010): 81-9. doi: https://doi.org/10.2147/opth.s9403
Cochener B, Fernández-Vega L, Alfonso JF, Maurel F, Meunier J, Berdeaux G. Spectacle independence and subjective satisfaction of ReSTOR multifocal intraocular lens after cataract or presbyopia surgery in two European countries. Clin Ophthalmol. 2010 Mar 04;4:81-9. doi: 10.2147/opth.s9403. PMID: 20234773; PMCID: PMC2835529.
Copy Download .nbib Format: NLM
Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions.

Therapie

Gueyffier F, Strang CB, Berdeaux G, França LR, Blin P, Massol J.
PMID: 23110837
Therapie. 2012 Jul-Aug;67(4):367-74. doi: 10.2515/therapie/2012042. Epub 2012 Nov 01.

Modeling consists in aggregating separate pieces of knowledge, according to a given structure and rules. It allows studying the behavior of more or less complex systems by simulation techniques. Modeling is used in different state-of-the-art technological domains (meteorology, aeronautics)....

Cite
Gueyffier F, Strang CB, Berdeaux G, et al. Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions. Therapie. 2012;67(4):367-74doi: 10.2515/therapie/2012042.
Gueyffier, F., Strang, C. B., Berdeaux, G., França, L. R., Blin, P., Massol, J. (2012). Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions. Therapie, 67(4), 367-74. https://doi.org/10.2515/therapie/2012042
Gueyffier, François, et al. "Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions." Therapie vol. 67,4 (2012): 367-74. doi: https://doi.org/10.2515/therapie/2012042
Gueyffier F, Strang CB, Berdeaux G, França LR, Blin P, Massol J. Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions. Therapie. 2012 Jul-Aug;67(4):367-74. doi: 10.2515/therapie/2012042. Epub 2012 Nov 01. PMID: 23110837.
Copy Download .nbib Format: NLM
Anabolic and Pro-metabolic Functions of CREB-CRTC in Skeletal Muscle: Advantages and Obstacles for Type 2 Diabetes and Cancer Cachexia.

Frontiers in endocrinology

Berdeaux R, Hutchins C.
PMID: 31428057
Front Endocrinol (Lausanne). 2019 Aug 02;10:535. doi: 10.3389/fendo.2019.00535. eCollection 2019.

cAMP is one of the earliest described mediators of hormone action in response to physiologic stress that allows acute stress responses and adaptation in every tissue. The classic role of cAMP signaling in metabolic tissues is to regulate nutrient...

Cite
Berdeaux R, Hutchins C. Anabolic and Pro-metabolic Functions of CREB-CRTC in Skeletal Muscle: Advantages and Obstacles for Type 2 Diabetes and Cancer Cachexia. Front Endocrinol (Lausanne). 2019;10:535doi: 10.3389/fendo.2019.00535.
Berdeaux, R., & Hutchins, C. (2019). Anabolic and Pro-metabolic Functions of CREB-CRTC in Skeletal Muscle: Advantages and Obstacles for Type 2 Diabetes and Cancer Cachexia. Frontiers in endocrinology, 10535. https://doi.org/10.3389/fendo.2019.00535
Berdeaux, Rebecca, and Hutchins, Chase. "Anabolic and Pro-metabolic Functions of CREB-CRTC in Skeletal Muscle: Advantages and Obstacles for Type 2 Diabetes and Cancer Cachexia." Frontiers in endocrinology vol. 10 (2019): 535. doi: https://doi.org/10.3389/fendo.2019.00535
Berdeaux R, Hutchins C. Anabolic and Pro-metabolic Functions of CREB-CRTC in Skeletal Muscle: Advantages and Obstacles for Type 2 Diabetes and Cancer Cachexia. Front Endocrinol (Lausanne). 2019 Aug 02;10:535. doi: 10.3389/fendo.2019.00535. eCollection 2019. PMID: 31428057; PMCID: PMC6688074.
Copy Download .nbib Format: NLM
Investigation of the molecular signature of greying hair shafts.

International journal of cosmetic science

Vyumvuhore R, Verzeaux L, Gilardeau S, Bordes S, Aymard E, Manfait M, Closs B.
PMID: 33713467
Int J Cosmet Sci. 2021 Jun;43(3):332-340. doi: 10.1111/ics.12700. Epub 2021 May 20.

OBJECTIVE: Hair greying (i.e. canitie) is a physiological process occurring with the loss of melanin production and deposition within the hair shafts. Many studies reported the oxidation as the main biological process underlying this defect of pigmentation. Even though...

Cite
Vyumvuhore R, Verzeaux L, Gilardeau S, et al. Investigation of the molecular signature of greying hair shafts. Int J Cosmet Sci. 2021;43(3):332-340doi: 10.1111/ics.12700.
Vyumvuhore, R., Verzeaux, L., Gilardeau, S., Bordes, S., Aymard, E., Manfait, M., & Closs, B. (2021). Investigation of the molecular signature of greying hair shafts. International journal of cosmetic science, 43(3), 332-340. https://doi.org/10.1111/ics.12700
Vyumvuhore, Raoul, et al. "Investigation of the molecular signature of greying hair shafts." International journal of cosmetic science vol. 43,3 (2021): 332-340. doi: https://doi.org/10.1111/ics.12700
Vyumvuhore R, Verzeaux L, Gilardeau S, Bordes S, Aymard E, Manfait M, Closs B. Investigation of the molecular signature of greying hair shafts. Int J Cosmet Sci. 2021 Jun;43(3):332-340. doi: 10.1111/ics.12700. Epub 2021 May 20. PMID: 33713467.
Copy Download .nbib Format: NLM
[Introducing a new polygraphy technique].

Annales medico-psychologiques

ALBE-FESSARD D, LEFEBVRE J, VERDEAUX G, VERDEAUX J.
PMID: 13181096
Ann Med Psychol (Paris). 1954 Apr;112(1):503-4.

No abstract available.

Cite
ALBE-FESSARD D, LEFEBVRE J, VERDEAUX G, et al. Présentation d'une nouvelle technique de polygraphie. [Introducing a new polygraphy technique]. Ann Med Psychol (Paris). 1954;112(1):503-4
ALBE-FESSARD, D., LEFEBVRE, J., VERDEAUX, G., & VERDEAUX, J. (1954). Présentation d'une nouvelle technique de polygraphie. [Introducing a new polygraphy technique]. Annales medico-psychologiques, 112(1), 503-4.
ALBE-FESSARD, D, et al. "Présentation d'une nouvelle technique de polygraphie." [Introducing a new polygraphy technique]. Annales medico-psychologiques vol. 112,1 (1954): 503-4.
ALBE-FESSARD D, LEFEBVRE J, VERDEAUX G, VERDEAUX J. Présentation d'une nouvelle technique de polygraphie. [Introducing a new polygraphy technique]. Ann Med Psychol (Paris). 1954 Apr;112(1):503-4. French. PMID: 13181096.
Copy Download .nbib Format: NLM
Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire.

Clinical ophthalmology (Auckland, N.Z.)

Nordmann JP, Baudouin C, Renard JP, Denis P, Regnault A, Berdeaux G.
PMID: 21191445
Clin Ophthalmol. 2010 Dec 08;4:1489-96. doi: 10.2147/OPTH.S11818.

OBJECTIVE: To identify poorly compliant glaucoma patients, using the Eye-Drop Satisfaction Questionnaire (EDSQ).METHODS: This was an observational cross-sectional study with compliance data collected by an electronic monitoring device. Patients with primary open-angle glaucoma or ocular hypertension completed the EDSQ,...

Cite
Nordmann JP, Baudouin C, Renard JP, et al. Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire. Clin Ophthalmol. 2010;4:1489-96doi: 10.2147/OPTH.S11818.
Nordmann, J. P., Baudouin, C., Renard, J. P., Denis, P., Regnault, A., & Berdeaux, G. (2010). Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire. Clinical ophthalmology (Auckland, N.Z.), 41489-96. https://doi.org/10.2147/OPTH.S11818
Nordmann, Jean-Philippe, et al. "Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire." Clinical ophthalmology (Auckland, N.Z.) vol. 4 (2010): 1489-96. doi: https://doi.org/10.2147/OPTH.S11818
Nordmann JP, Baudouin C, Renard JP, Denis P, Regnault A, Berdeaux G. Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire. Clin Ophthalmol. 2010 Dec 08;4:1489-96. doi: 10.2147/OPTH.S11818. PMID: 21191445; PMCID: PMC3009996.
Copy Download .nbib Format: NLM
Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database.

Clinical ophthalmology (Auckland, N.Z.)

Denis P, Lafuma A, Berdeaux G.
PMID: 19668723
Clin Ophthalmol. 2008 Jun;2(2):321-9. doi: 10.2147/opth.s2832.

The persistence and costs of carbonic anhydrase inhibitors + prostaglandin analogues (CAIs + PGAs) vs alpha-2 adrenergic agonists + prostaglandin analogues (alpha-2 agonists + PGAs) were compared, based on The United Kingdom General Practitioner Research Database. Patients with a...

Cite
Denis P, Lafuma A, Berdeaux G. Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database. Clin Ophthalmol. 2008;2(2):321-9doi: 10.2147/opth.s2832.
Denis, P., Lafuma, A., & Berdeaux, G. (2008). Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database. Clinical ophthalmology (Auckland, N.Z.), 2(2), 321-9. https://doi.org/10.2147/opth.s2832
Denis, Philippe, et al. "Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database." Clinical ophthalmology (Auckland, N.Z.) vol. 2,2 (2008): 321-9. doi: https://doi.org/10.2147/opth.s2832
Denis P, Lafuma A, Berdeaux G. Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database. Clin Ophthalmol. 2008 Jun;2(2):321-9. doi: 10.2147/opth.s2832. PMID: 19668723; PMCID: PMC2693992.
Copy Download .nbib Format: NLM
Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden.

Clinical ophthalmology (Auckland, N.Z.)

Bergström A, Maurel F, Le Pen C, Lamure E, Kent M, Bardoulat I, Berdeaux G.
PMID: 19714225
Clin Ophthalmol. 2009;3:471-81. doi: 10.2147/opth.s6811. Epub 2009 Aug 20.

BACKGROUND: To compare the daily costs of 3 prostaglandin analogues (bimatoprost, latanoprost, travoprost), alone, and associated with timolol in 4 European countries (Denmark, Finland, Germany, and Sweden).METHODS: Six glaucoma products were sampled by buying 5 bottles from 1 suburban...

Cite
Bergström A, Maurel F, Le Pen C, et al. Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden. Clin Ophthalmol. 2009;3:471-81doi: 10.2147/opth.s6811.
Bergström, A., Maurel, F., Le Pen, C., Lamure, E., Kent, M., Bardoulat, I., & Berdeaux, G. (2009). Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden. Clinical ophthalmology (Auckland, N.Z.), 3471-81. https://doi.org/10.2147/opth.s6811
Bergström, Anders, et al. "Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden." Clinical ophthalmology (Auckland, N.Z.) vol. 3 (2009): 471-81. doi: https://doi.org/10.2147/opth.s6811
Bergström A, Maurel F, Le Pen C, Lamure E, Kent M, Bardoulat I, Berdeaux G. Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden. Clin Ophthalmol. 2009;3:471-81. doi: 10.2147/opth.s6811. Epub 2009 Aug 20. PMID: 19714225; PMCID: PMC2732058.
Copy Download .nbib Format: NLM
Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue.

Journal of stem cells & regenerative medicine

Habeler W, Ghaleh B, Barthelemy I, Plancheron A, Bizé A, Carlos-Sampedrano C, Chetboul V, Berdeaux A, Pucéat M, Peschanski M, Blot S, Monville C.
PMID: 24693175
J Stem Cells Regen Med. 2011 Oct 30;7(2):80-6. eCollection 2011.

Duchenne muscular dystrophy is characterized by progressive muscle weakness and early death resulting from dystrophin deficiency. Spontaneous canine muscular disorders are interesting settings to evaluate the relevance of innovative therapies in human using pre-clinical trials.

Cite
Habeler W, Ghaleh B, Barthelemy I, et al. Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue. J Stem Cells Regen Med. 2011;7(2):80-6
Habeler, W., Ghaleh, B., Barthelemy, I., Plancheron, A., Bizé, A., Carlos-Sampedrano, C., Chetboul, V., Berdeaux, A., Pucéat, M., Peschanski, M., Blot, S., & Monville, C. (2011). Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue. Journal of stem cells & regenerative medicine, 7(2), 80-6.
Habeler, W, et al. "Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue." Journal of stem cells & regenerative medicine vol. 7,2 (2011): 80-6.
Habeler W, Ghaleh B, Barthelemy I, Plancheron A, Bizé A, Carlos-Sampedrano C, Chetboul V, Berdeaux A, Pucéat M, Peschanski M, Blot S, Monville C. Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue. J Stem Cells Regen Med. 2011 Oct 30;7(2):80-6. eCollection 2011. PMID: 24693175; PMCID: PMC3908277.
Copy Download .nbib Format: NLM
Defining a Role for G-Protein Coupled Receptor/cAMP/CRE-Binding Protein Signaling in Hair Follicle Stem Cell Activation.

The Journal of investigative dermatology

Miranda M, Avila I, Esparza J, Shwartz Y, Hsu YC, Berdeaux R, Lowry WE.
PMID: 34280464
J Invest Dermatol. 2022 Jan;142(1):53-64.e3. doi: 10.1016/j.jid.2021.05.031. Epub 2021 Jul 17.

Manipulation of adrenergic signaling has been shown experimentally and clinically to affect hair follicle growth. In this study, we provide direct evidence that canonical cAMP/CRE-binding protein signaling through adrenergic receptors can regulate hair follicle stem cell (HFSC) activation and...

Cite
Miranda M, Avila I, Esparza J, et al. Defining a Role for G-Protein Coupled Receptor/cAMP/CRE-Binding Protein Signaling in Hair Follicle Stem Cell Activation. J Invest Dermatol. 2021;142(1):53-64.e3doi: 10.1016/j.jid.2021.05.031.
Miranda, M., Avila, I., Esparza, J., Shwartz, Y., Hsu, Y. C., Berdeaux, R., & Lowry, W. E. (2022). Defining a Role for G-Protein Coupled Receptor/cAMP/CRE-Binding Protein Signaling in Hair Follicle Stem Cell Activation. The Journal of investigative dermatology, 142(1), 53-64.e3. https://doi.org/10.1016/j.jid.2021.05.031
Miranda, Matilde, et al. "Defining a Role for G-Protein Coupled Receptor/cAMP/CRE-Binding Protein Signaling in Hair Follicle Stem Cell Activation." The Journal of investigative dermatology vol. 142,1 (2022): 53-64.e3. doi: https://doi.org/10.1016/j.jid.2021.05.031
Miranda M, Avila I, Esparza J, Shwartz Y, Hsu YC, Berdeaux R, Lowry WE. Defining a Role for G-Protein Coupled Receptor/cAMP/CRE-Binding Protein Signaling in Hair Follicle Stem Cell Activation. J Invest Dermatol. 2022 Jan;142(1):53-64.e3. doi: 10.1016/j.jid.2021.05.031. Epub 2021 Jul 17. PMID: 34280464.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 39 entries